A case of novel coronavirus disease after combination therapy with nivolumab and ipilimumab for metastatic renal cell carcinoma.

Yu KijimaTomokazu ShimizuShinya KatoEri SekidoKana KanoMakoto ToguchiToshihide HoriuchiHiroshi TomaShoichi IidaToshio Takagi

Published in: IJU case reports (2021)

We administered nivolumab and ipilimumab combination therapy as treatment for metastatic renal cell carcinoma. No side effects or immune-related adverse events were observed for a short time.

Keyphrases

combination therapy
metastatic renal cell carcinoma
coronavirus disease
smoking cessation